SUMMARY - Health Canada Organization
In a small clinic in rural Saskatchewan, Dr. Aris Thorne reviews a batch of newly approved pharmaceuticals. The approval process, managed by federal regulators, has ensured the drugs meet rigorous safety standards, yet the timeline for market entry remains a source of professional frustration. For Dr. Thorne, the structure of Health Canada represents a necessary gatekeeper for patient safety, but its bureaucratic inertia often conflicts with the urgent clinical needs of his patients who are waiting for life-saving treatments.